Core Viewpoint - Fosun Group is actively expanding its capital footprint, with its subsidiary Yiyao Technology initiating the IPO process to list on the A-share market, which would mark another addition to its portfolio of listed companies [1][3]. Group 1: Company Overview - Yiyao Technology, established on July 31, 2018, has a registered capital of approximately 625 million yuan and currently has no controlling shareholder [3]. - The largest shareholder of Yiyao Technology is Ningbo Meishan Bonded Port Area Fuliang Investment Partnership, holding 22.16% of the shares, which is backed by Fosun High Technology Group [3][4]. - Fosun Group has a total of 10 listed companies, including 6 on the A-share market and 4 on the Hong Kong stock exchange, with a focus on sectors such as health, happiness, wealth, and intelligent manufacturing [6][7]. Group 2: Financial Performance - The financial performance of Fosun's listed companies shows significant divergence, with 6 A-share companies reporting a decline in net profits, reflecting operational pressures in certain sectors [1][8]. - In the first three quarters of 2025, among the 6 A-share companies, Shanghai Steel Union led with revenue of approximately 57.32 billion yuan, while Fosun Pharma and Yuyuan Holdings followed with revenues of 29.39 billion yuan and 28.4 billion yuan, respectively [8]. - In the Hong Kong market, Fosun International and Furuya Medical Technology reported a decline in net profits, while Fuhong Hanlin showed a year-on-year increase in net profit [8]. Group 3: Strategic Direction - The push for IPOs among Fosun's subsidiaries is seen as a strategic move to enhance capital efficiency and meet business growth demands, particularly in the high-tech intelligent manufacturing sector [4][7]. - Fosun's strategy is shifting from diversified expansion to a focus on core sectors, aiming to optimize cash flow and strengthen its capital platform in health and intelligent manufacturing [7].

Group 1 - Fosun International's subsidiary, Shanghai Yiyao Technology Co., Ltd., has initiated the IPO process, aiming to expand its capital footprint in the A-share market [1][3] - Under the leadership of Guo Guangchang, Fosun has evolved into an innovation-driven global family consumption industry group, focusing on a happiness ecosystem centered around health, happiness, and wealth [1][4] - Currently, Fosun controls six A-share listed companies and four Hong Kong listed companies, with four of the A-share companies having a market capitalization exceeding 100 billion [1][6] Group 2 - The performance of Fosun's listed companies shows significant divergence, with six companies reporting a decline in net profit, reflecting operational pressures in certain sectors [1][8] - In the first three quarters of 2025, six A-share companies reported revenues exceeding 2 billion, with Shanghai Steel Union leading at approximately 57.32 billion [8] - Among the A-share companies, only Fosun Pharma and Shanghai Steel Union reported year-on-year growth in net profit, while others, including Yuyuan and Hainan Mining, experienced declines [8][9] Group 3 - Yiyao Technology, established in July 2018, focuses on providing high-tech solutions across various intelligent manufacturing sectors, including automotive and food automation [3][4] - Fosun's total assets exceeded 796.5 billion as of December 31, 2024, with a significant portion of revenue coming from international operations [4][6] - The group is shifting its strategy from diversification to deepening its core sectors, particularly in health and intelligent manufacturing, to optimize capital structure and enhance cash flow [7]